D
OptimizeRx Corporation OPRX
$17.00 -$0.25-1.45% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 138.21% 68.13% 98.12% -218.46% 3.65%
Total Depreciation and Amortization -0.20% 0.70% 25.62% 139.95% 139.95%
Total Amortization of Deferred Charges 101.58% 4.74% -19.12% 470.83% 438.30%
Total Other Non-Cash Items -48.73% -50.63% -62.05% 145.78% -19.70%
Change in Net Operating Assets -95.26% -29.81% 61.77% 174.24% 127.68%
Cash from Operations 483.25% 82.44% 103.16% 21.59% 133.01%
Capital Expenditure 77.78% 15.63% -240.00% 45.45% -125.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 15.00% 52.89% -100.19% 92.43% -101.23%
Cash from Investing 48.24% 45.10% 99.54% 90.89% -102.64%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -800.00% 0.00% -46.20% -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock 98.80% 37.86% -121.92% 34.69% 94.54%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -392.35% 8.28% -107.80% -52.87% 87.78%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 105.50% 140.98% -169.89% 906.03% 96.71%